Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome

Conclusions: Improved SCLC tumor survival seen in patients with LEMS and SCLC may not be due solely to lead time bias, given that survival advantage remains after allowing for other prognostic factors and that the same degree of survival advantage is not seen in patients with paraneoplastic neurologic syndromes other than LEMS presenting before SCLC diagnosis.

http://www.neurology.org/cgi/content/short/88/14/1334?rss=1

Source: Neurology - April 3, 2017 Category: Neurology Authors: Maddison, P., Gozzard, P., Grainge, M. J., Lang, B. Tags: Lambert-Eaton syndrome, Paraneoplastic syndrome ARTICLE Source Type: research